Atlas Trials

Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer

Clinical trial NCT00694200 · TERMINATED

Trial details

NCT number
NCT00694200
Sponsor
Hellenic Oncology Research Group
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2008-04-01
Primary completion
2009-12-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.